Search

everythinglearnresearchcommunity

for

Search:↓

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Higher androgen levels do not cause baldness in men.

Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

FDG PET/CT scans can change cancer treatment plans for dogs.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Polyesters show promise for repairing damaged blood vessels.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Healthcare providers need better education and policies to serve transgender individuals effectively.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Nanostructured lipid carriers deliver lidocaine to the skin better than nanoethosomes.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.